Evidence map›Paper›PMID 35785391›Full record

ArticleJournal of arrhythmia2022

The Japanese lead extraction registry (J-LEX): Annual report 2020.

Morio Shoda, Kengo Kusano, Masahiko Goya, Nobuhiro Nishii, Katsuhiko Imai, Yoji Okamoto, Michio Nagashima, Misa Takegami, Yoko M Nakao, Yoshitaka Iwanaga and 4 more

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Morio ShodaClinical Research Division of Heart Rhythm Management, Department of Cardiology Tokyo Women's Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-1772-6823
Kengo KusanoDepartment of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita Japan.
Masahiko GoyaDepartment of Cardiovascular Medicine, Heart Rhythm Center Tokyo Medical and Dental University Tokyo Japan.
Nobuhiro NishiiDepartment of Cardiovascular Therapeutics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.ORCID https://orcid.org/0000-0003-2403-4152
Katsuhiko ImaiDepartment of Cardiovascular Surgery, National Hospital Organization Kure Medical Center & Chugoku Cancer Center Kure Japan.
Yoji OkamotoAoi Home Healthcare Clinic Okayama Japan.
Michio NagashimaDepartment of Cardiology Kokura Memoria Hospital Kitakyushu Japan.
Misa TakegamiDepartment of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita Japan.
Yoko M NakaoDepartment of Medical and Health Information Management National Cerebral and Cardiovascular Center Suita Japan.
Yoshitaka IwanagaDepartment of Medical and Health Information Management National Cerebral and Cardiovascular Center Suita Japan.
Yoshihiro MiyamotoDepartment of Medical and Health Information Management National Cerebral and Cardiovascular Center Suita Japan.
Akihiko NogamiDepartment of Cardiology, Faculty of Medicine University of Tsukuba Tsukuba Japan.
Wataru ShimizuDepartment of Cardiovascular Medicine Nippon Medical School Tokyo Japan.
J‐LEX registry investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Japanese Heart Rhythm Society established a nationwide, mandatory, multi-center, prospective, observational registry of transvenous lead extraction (TLE) named the Japanese lead extraction registry (J-LEX) in 2018. We have published the first annual report of J-LEX with 661 cases from 42 hospitals. The second annual report of J-LEX in 2020 enrolled increased numbers of 785 cases from 75 hospitals. TLE procedure was attempted on patients with an average age of 71.7 years old, male in 72.5% in the hybrid operating room in 57.9%, and in standard OR with a C-arm fluoroscope in 18.7%. The indication of TLE was an infection in 62.8% and the guideline classification was class-I in 67.4% and class-IIa in 23.8%. The average implantation duration of target leads was 7.9 years. Complete removal was achieved in 96.6% of the target leads and clinical success in 98.1% of the patients. Perioperative complications were observed in 7.1% of the patients. One patient died during a TLE operation and the other three patients died in-hospital (cardiac death in one patient and non-cardiac in two patients). Although the annual J-LEX report in 2020 demonstrated an increased number of TLE procedures despite the first pandemic year of coronavirus disease-2019 (COVID-19), perioperative complications increased a little in comparison with J-LEX 2019.

Indexed as

complicationimplantable cardioverter defibrillatorlead extractionpacemakerregistry

Identifiers

PMID35785391
PMCPMC9237310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.